Peter C Lucas

13PUBLICATIONS
104CO-AUTHORS
Cancer cell biologyPredictive and prognostic markersMolecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 27, 2026
Systemic and local chronic inflammation and hormone disposition promote a tumor-permissive environment for breast cancer in older women.

|May 06, 2026
Non-invasive profiling of the tumour microenvironment with spatial ecotypes.

|Jun 27, 2025
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacy.

Dong Hu, Xiaoshuang Lyu, Zheqi Li

|Jul 24, 2024
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial.

Priya Rastogi, Hanna Bandos, Peter C Lucas

|Jul 23, 2024
Spatial molecular profiling of mixed invasive ductal and lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutations.

Osama Shiraz Shah, Azadeh Nasrazadani, Julia Foldi

|Feb 20, 2024
Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial.

Eleftherios P Mamounas, Hanna Bandos, Priya Rastogi

Pageof 3

Frequent Collaborators

6 joint publications

Steffi Oesterreich

6 joint publications

Adrian V Lee

5 joint publications

Norman Wolmark

3 joint publications

Adam M Brufsky